Analyst Research

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cardiovascular Systems Inc Issues Q4 2013 Guidance In Line With Analysts' Estimates


Wednesday, 1 May 2013 04:00pm EDT 

Cardiovascular Systems Inc announced that for the fourth quarter of 2013, it expects revenue to a range of $26.7 million to $27.7 million and net loss in the range of $(6.8) million to $(7.4) million, or loss per common share ranging from $(0.28) to $(0.31). According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $27.0 million, net income of $(6.9) and EPS of $(0.30) for the fourth quarter of 2013. 

Company Quote

26.86
-0.13 -0.48%
19 Sep 2014